CN101757559B - Medicament for treating gastropathy - Google Patents
Medicament for treating gastropathy Download PDFInfo
- Publication number
- CN101757559B CN101757559B CN2009102274734A CN200910227473A CN101757559B CN 101757559 B CN101757559 B CN 101757559B CN 2009102274734 A CN2009102274734 A CN 2009102274734A CN 200910227473 A CN200910227473 A CN 200910227473A CN 101757559 B CN101757559 B CN 101757559B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- grams
- furazolidone
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament and discloses a medicament for treating gastropathy, which comprises the flowing components in parts by weight: 5-15 parts of radix bupleuri, 5-12 parts of Chinese angelica, 10-20 parts of white paeony root, 5-12 parts of white atractylodes rhizome, 5-15 parts of radix curcumae, 10-18 parts of red-rooted salvia root, 13-18 parts of lily, 8-15 parts of poria, 10-20 parts of tuber fleeceflower stem, 3-8 parts of radix glycyrrhizae preparata, 5-15 parts of Callus gallus domosticus Brisson, and 0.05-0.15 part of furazolidone. The medicament is prepared by the steps of: crushing radix bupleuri, Chinese angelica, white paeony root, white atractylodes rhizome, radix curcumae, red-rooted salvia root, lily, Poria cocos, tuber fleeceflower stem, radix glycyrrhizae preparata, Callus gallus domosticus Brisson, and furazolidone; screening and mixing; and finally maxing into powder, water-bindered pills or capsules. The medicament is used for the treatment of gastropathy, such as chronic superficial gastritis, ulcer of stomach and ulcer and the like and has the advantages of less medicine dose, quick medical effect, easy taking, low cost, good safety and reliability and excellent treatment effect. The total effective rate of the medicine reaches 100%, shown by 267 cases of clinical test.
Description
Technical field:
The present invention relates to medicine, further is the medicine of treatment gastropathy, especially for Chinese and western drugses such as treatment gastritis, gastroduodenal ulcers.
Background technology:
Gastropathy comprises gastritis, gastric ulcer and duodenal ulcer, gastric perforation etc., gives people's life and healthy life, has caused great misery and harm.Gastropathy belongs to frequently-occurring disease, according to interrelated data, along with the raising of material life; The continuous increase of the quickening of rhythm of life and operating pressure; The sickness rate of gastropathy increases, and becomes the great illness that is only second to cardio-cerebral diseases, also is domestic and international medical circle obstinate disease.The drug kinds that is used for gastrotherapy is many, but or cost an arm and a leg, or poor effect, treatment cycle length is difficult to reach the purpose of radical cure.
Therefore, it is good to seek to have therapeutic effect, Chinese medicine that untoward reaction is few or Chinese medicine and western medicine mixture just seem very urgent and needs.For this reason, the inventor studied intensively and explores through the more than ten years, successfully developed the specific medicament that can effect a radical cure the routed intestinal of gastritis, stomach and duodenum finally.
Summary of the invention:
The object of the invention is exactly the defective that exists in the existing Drug therapy, and a kind of medicine of treating gastropathy is provided, and this medicine is mainly used in the treatment of gastropathy such as chronic superficial gastritis, gastric and duodenal ulcers, and consumption is few, drug effect is fast, taking convenience, and cost is low.
The objective of the invention is to realize through following scheme: a kind of medicine of treating gastropathy is characterized in that being made up of following bulk drugs: 5～15 parts of Radix Bupleuri, 5～12 parts of Radix Angelicae Sinensis, 10～20 parts of the Radix Paeoniae Albas; 5～12 parts of the Rhizoma Atractylodis Macrocephalaes, 5～15 parts of Radix Curcumaes, 10～18 parts of Radix Salviae Miltiorrhizaes; 13～18 parts of Bulbus Liliies, 8～15 parts in Poria, 10～20 parts of Caulis Polygoni Multiflori; 3～8 parts in Radix Glycyrrhizae (processing), 5～15 parts of Ovum Gallus domesticus crustas, 0.05～0.15 part of furazolidone.
The present invention can further realize through following scheme:
Preferred version is: 8～12 parts of Radix Bupleuri, 7～10 parts of Radix Angelicae Sinensis, 13～17 parts of the Radix Paeoniae Albas, 7～10 parts of the Rhizoma Atractylodis Macrocephalaes; 8～12 parts of Radix Curcumaes, 12～16 parts of Radix Salviae Miltiorrhizaes, 14～17 parts of Bulbus Liliies, 10～14 parts in Poria; 13～17 parts of Caulis Polygoni Multiflori, 4～7 parts in Radix Glycyrrhizae (processing), 8～12 parts of Ovum Gallus domesticus crustas, 0.08～0.12 part of furazolidone.
Preferred plan is: 10 parts of Radix Bupleuri, 9 parts of Radix Angelicae Sinensis, 15 parts of the Radix Paeoniae Albas, 9 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of Radix Curcumaes, 14 parts of Radix Salviae Miltiorrhizaes, 15 parts of Bulbus Liliies, 12 parts in Poria, 15 parts of Caulis Polygoni Multiflori, 6 parts in Radix Glycyrrhizae (processing), 10 parts of Ovum Gallus domesticus crustas, 0.1 part of furazolidone.
Manufacture method: Radix Bupleuri, Radix Angelicae Sinensis, the Radix Paeoniae Alba, the Rhizoma Atractylodis Macrocephalae, Radix Curcumae, Radix Salviae Miltiorrhizae, Bulbus Lilii, Poria, Caulis Polygoni Multiflori, Radix Glycyrrhizae, Ovum Gallus domesticus crusta, furazolidone are pulverized, sieved, be mixed and made into powder, the watered pill or capsule.
The present invention can also further realize through following scheme:
Configuration mechanism of the present invention: Radix Bupleuri has the effect of dispersing the stagnated live-QI to relieve the stagnation of QI, elevate a turnable ladder yang-energy.Radix Angelicae Sinensis, the effect that having enriches blood invigorated blood circulation, held up empty benefit damage, loosening bowel to relieve constipation.The Radix Paeoniae Alba has the effect of the yin fluid astringing of nourishing blood, suppressing liver-YANG, easing the affected liver to relieve pain.The Rhizoma Atractylodis Macrocephalae has the effect of invigorating the spleen and replenishing QI, stomach strengthening, antidiarrheal, dehumidifying.Radix Curcumae has the effect of regulating qi to disperse stagnation.Radix Salviae Miltiorrhizae has stasis-dispelling and pain-killing, an effect of the relieving restlessness that clears away heart-fire.Bulbus Lilii has the effect of clearing away heart-fire for tranquillization.Poria has the effect of eliminating damp, detoxifying, spleen invigorating mind calming.Caulis Polygoni Multiflori, the effect of have nourishing heart, calm the nerves, dispeling the wind.Radix Glycyrrhizae has the effect of QI invigorating invigorating middle warmer, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.Ovum Gallus domesticus crusta has that suppressing the hyperactive liver and subsiding YANG, hard masses softening and resolving, convergence are wet admittedly, the effect of relieving gastric hyperacidity to alleviate stomachache.Furazolidone (has another name called: furazolidone, molecular formula: C
8H
7O
5N
3), have the effect of anti-inflammation, salmonella, shigella dysenteriae, escherichia coli, Bacillus proteus, streptococcus and staphylococcus etc. all there are antibacterial action, be mainly used in diseases such as bacillary dysentery, enteritis, typhoid fever, paratyphoid fever.
All medicine compatibilities of the present invention have effects such as regulating qi to disperse stagnation, promoting blood circulation and stopping pain, soothing the liver detoxifcation, QI invigorating invigorating middle warmer, anti-inflammation, enhancing body resistance.
The invention has the beneficial effects as follows: medicine of the present invention, be used for the treatment of gastropathy such as chronic superficial gastritis, gastric and duodenal ulcers, outstanding feature is that consumption is few, drug effect is fast, taking convenience, cost is low, safe and reliable, curative effect is preferable.As far as most of cases, in very short time, can effect a radical cure gastropathy usually.Show that with 267 routine clinical trials total effective rate reaches 100%.
Testing data:
1, cure mainly:
Cure mainly gastropathy such as shallow table property chronic gastritis, gastric and duodenal ulcers, stomach pyloric ulcer.
2, case statistics:
Treat 267 examples, the superficial gastritis, gastric and duodenal ulcers 193 examples that cause of Deficiency and coldness of spleen and stomach wherein, the gastral cavilty distending pain that liver-fire invading the stomach causes, belch pantothenic acid, being irritable and getting angry easily, uneasy sleeping at night, symptoms such as inappetence 74 examples.Wherein male's 189 examples, women's 78 examples, at 22 years old-65 years old age, the longest course of disease person is 12 years.
3, Therapeutic Method:
Adult every day 3 times, one time 6 gram, boiled water takes.7 is a course of treatment.
4, contraindication:
Period in a medicine, the diet pork, spicy food, muscle power is excessive, anger is drunk.
5, efficacy assessment standard:
Recovery from illness: all diseases such as the gastral cavilty distending pain that is caused by gastropathy, belch pantothenic acid, being irritable and getting angry easily, uneasy sleeping at night, inappetence all disappear, and diet is normal, observes three months no change persons.Effectively: all diseases are eliminated basically or are obviously disappeared, and diet basically normally or obviously turns for the better.Invalid: the person that do not reach the effective target.
6, therapeutic effect:
Totally 267 examples are wherein cured 229 examples, account for 85.8%, and effective 38 examples account for 14.2%, invalid 0 example, total effective rate 100%.See following table for details:
| Type | The example number | The man | The woman | Cure (example) | Effectively (example) | Total effective rate (%) |
| Deficiency and coldness of spleen and stomach | 193 | 128 | 65 | 161 | 32 | 100.0 |
| Liver-fire invading the stomach | 74 | 61 | 13 | 68 | 6 | 100.0 |
7, model case introduction:
Case 1: Zhao so-and-so, man, 47 years old; Live Miao Pu newly developed area, road junction town, Hua County, Henan Province, the gastropathy that the trouble Deficiency and coldness of spleen and stomach causes 5 years, main suit's stomach becomes regular pain; Promptly after at 10 o'clock in the morning, after at ten six o'clock in afternoon, show effect night sometimes; Receive the cold shut stomach gas that rises to meet heat symptom-complex and disappear, radiation heart back is stomach and duodenal bulbar ulcer through hospital's barivm meal fluoroscopy (screem).Take this medicine, the regulating qi-flowing for strengthening spleen warming spleen and stomach for dispelling cold quickens ulcer healing.Take after ten days and all heal, follow up a case by regular visits to not recurrence in 10 years so far at disease.
Case 2: journey so-and-so, the man, 54 years old, live the Zhengzhou City, Henan Province, main suit's upper abdomen dull pain, when hungry pain very, it is slow to eat pain, sore spot is fixed, or gastral cavity abdominal distention is vexed, and is noisy scorching hot, nausea and vomiting, belch pantothenic acid once was diagnosed as gastric and duodenal ulcers in hospital.Take this medicine, symptom is slow slightly after five days, takes prescription then 20 days, all disease recoveries from illness.Gastroscope check ulcer transference cure after half a year.
Case 3: Lee, the man, 42 years old, live road junction town, Hua County, Henan Province, main suit's vague epigastralgia, outbreak when hungry, accompany noisy, acid regurgitation, borborygmus, shortness of breath and fatigue, red tongue is liked warm pain relieved by pressing, body constitution is thin and weak, gastroscope shows: chronic gastritis.Take this medicine, all diseases were all healed in six days.Follow up a case by regular visits to and do not recur half a year.
The specific embodiment:
Below in conjunction with embodiment the present invention is done further narration:
Embodiment 1: choose: Radix Bupleuri 8 grams, Radix Angelicae Sinensis 7 grams, the Radix Paeoniae Alba 13 grams, the Rhizoma Atractylodis Macrocephalae 7 grams, Radix Curcumae 8 grams, Radix Salviae Miltiorrhizae 12 grams, Bulbus Lilii 14 grams, Poria 10 grams, Caulis Polygoni Multiflori 13 grams, Radix Glycyrrhizae (processing) 4 grams, Ovum Gallus domesticus crusta 8 grams, furazolidone 0.08 gram.
Manufacture method: Radix Bupleuri, Radix Angelicae Sinensis, the Radix Paeoniae Alba, the Rhizoma Atractylodis Macrocephalae, Radix Curcumae, Radix Salviae Miltiorrhizae, Bulbus Lilii, Poria, Caulis Polygoni Multiflori, Radix Glycyrrhizae, Ovum Gallus domesticus crusta, furazolidone are pulverized, sieved, be mixed and made into powder, the watered pill or capsule.
Embodiment 2: choose: Radix Bupleuri 12 grams, Radix Angelicae Sinensis 10 grams, the Radix Paeoniae Alba 17 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Radix Curcumae 12 grams, Radix Salviae Miltiorrhizae 16 grams, Bulbus Lilii 17 grams, Poria 14 grams, Caulis Polygoni Multiflori 17 grams, Radix Glycyrrhizae (processing) 7 grams, Ovum Gallus domesticus crusta 12 grams, furazolidone 0.12 gram.
Manufacture method is with embodiment 1.
Embodiment 3: choose: Radix Bupleuri 8 grams, Radix Angelicae Sinensis 10 grams, the Radix Paeoniae Alba 13 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Radix Curcumae 8 grams, Radix Salviae Miltiorrhizae 16 grams, Bulbus Lilii 14 grams, Poria 14 grams, Caulis Polygoni Multiflori 13 grams, Radix Glycyrrhizae (processing) 4 grams, Ovum Gallus domesticus crusta 12 grams, furazolidone 0.08 gram.
Manufacture method is with embodiment 1.
Embodiment 4: choose: Radix Bupleuri 12 grams, Radix Angelicae Sinensis 7 grams, the Radix Paeoniae Alba 17 grams, the Rhizoma Atractylodis Macrocephalae 7 grams, Radix Curcumae 12 grams, Radix Salviae Miltiorrhizae 12 grams, Bulbus Lilii 17 grams, Poria 10 grams, Caulis Polygoni Multiflori 17 grams, Radix Glycyrrhizae (processing) 7 grams, Ovum Gallus domesticus crusta 8 grams, furazolidone 0.12 gram.
Manufacture method is with embodiment 1.
The above; Be merely the specific embodiment of the present invention, but protection scope of the present invention is not limited thereto, any technical staff who is familiar with the present technique field is in the technical scope that the present invention discloses; The variation that can expect easily or replacement all should be encompassed within protection scope of the present invention.
Claims (3)
1. a medicine of treating gastropathy is characterized in that being made up of following bulk drugs: 5～15 parts of Radix Bupleuri, 5～12 parts of Radix Angelicae Sinensis, 10～20 parts of the Radix Paeoniae Albas; 5～12 parts of the Rhizoma Atractylodis Macrocephalaes, 5～15 parts of Radix Curcumaes, 10～18 parts of Radix Salviae Miltiorrhizaes; 13～18 parts of Bulbus Liliies, 8～15 parts in Poria, 10～20 parts of Caulis Polygoni Multiflori; 3～8 parts in Radix Glycyrrhizae, 5～15 parts of Ovum Gallus domesticus crustas, 0.05～0.15 part of furazolidone.
2. the medicine of treatment gastropathy according to claim 1 is characterized in that the component of each crude drug is: 10 parts of Radix Bupleuri, 9 parts of Radix Angelicae Sinensis, 15 parts of the Radix Paeoniae Albas, 9 parts of the Rhizoma Atractylodis Macrocephalaes; 10 parts of Radix Curcumaes, 14 parts of Radix Salviae Miltiorrhizaes, 15 parts of Bulbus Liliies, 12 parts in Poria; 15 parts of Caulis Polygoni Multiflori, 6 parts in Radix Glycyrrhizae, 10 parts of Ovum Gallus domesticus crustas, 0.1 part of furazolidone.
3. the manufacture method of the medicine of treatment gastropathy according to claim 1 and 2; It is characterized in that: Radix Bupleuri, Radix Angelicae Sinensis, the Radix Paeoniae Alba, the Rhizoma Atractylodis Macrocephalae, Radix Curcumae, Radix Salviae Miltiorrhizae, Bulbus Lilii, Poria, Caulis Polygoni Multiflori, Radix Glycyrrhizae, Ovum Gallus domesticus crusta, furazolidone are pulverized; Sieve, be mixed and made into the powder or the watered pill or capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102274734A CN101757559B (en) | 2009-12-15 | 2009-12-15 | Medicament for treating gastropathy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102274734A CN101757559B (en) | 2009-12-15 | 2009-12-15 | Medicament for treating gastropathy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101757559A CN101757559A (en) | 2010-06-30 |
| CN101757559B true CN101757559B (en) | 2012-07-25 |
Family
ID=42489043
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102274734A Expired - Fee Related CN101757559B (en) | 2009-12-15 | 2009-12-15 | Medicament for treating gastropathy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101757559B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102133365B (en) * | 2010-10-27 | 2012-07-25 | 宋爱民 | Traditional Chinese medicine preparation for treating gastric ulcer |
| CN102579854B (en) * | 2011-01-06 | 2013-05-08 | 陈玉忠 | Medicament for treating hemorrhagic gastric ulcer and duodenum ulceration |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1381265A (en) * | 2002-05-01 | 2002-11-27 | 孙孝 | Medicine for treating cholecystitis and its preparing process |
| CN1437977A (en) * | 2003-01-13 | 2003-08-27 | 许新琳 | Medicine for treating lung cancer |
| CN1879853A (en) * | 2006-05-14 | 2006-12-20 | 干石亮 | A medicinal liquor for treating qi-stagnant damp-obstruction type cirrhosis ascites and method for preparing same |
| CN1919331A (en) * | 2006-08-22 | 2007-02-28 | 夏金陵 | Chinese medicine composition for treating gastritis and preparing method thereof |
| CN101116739A (en) * | 2007-08-14 | 2008-02-06 | 廖啟义 | Chinese traditional medicine for treating acute and chronic hepatitis |
| CN101406656A (en) * | 2008-10-23 | 2009-04-15 | 李艳 | Medicament for treating hepatic cirrhosis with hypoproteinemia after hepatitis |
| CN101444613A (en) * | 2008-12-19 | 2009-06-03 | 宗翠红 | Traditional Chinese medicine formula for treating chronic hepatitis |
-
2009
- 2009-12-15 CN CN2009102274734A patent/CN101757559B/en not_active Expired - Fee Related
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1381265A (en) * | 2002-05-01 | 2002-11-27 | 孙孝 | Medicine for treating cholecystitis and its preparing process |
| CN1437977A (en) * | 2003-01-13 | 2003-08-27 | 许新琳 | Medicine for treating lung cancer |
| CN1879853A (en) * | 2006-05-14 | 2006-12-20 | 干石亮 | A medicinal liquor for treating qi-stagnant damp-obstruction type cirrhosis ascites and method for preparing same |
| CN1919331A (en) * | 2006-08-22 | 2007-02-28 | 夏金陵 | Chinese medicine composition for treating gastritis and preparing method thereof |
| CN101116739A (en) * | 2007-08-14 | 2008-02-06 | 廖啟义 | Chinese traditional medicine for treating acute and chronic hepatitis |
| CN101406656A (en) * | 2008-10-23 | 2009-04-15 | 李艳 | Medicament for treating hepatic cirrhosis with hypoproteinemia after hepatitis |
| CN101444613A (en) * | 2008-12-19 | 2009-06-03 | 宗翠红 | Traditional Chinese medicine formula for treating chronic hepatitis |
Non-Patent Citations (7)
| Title |
|---|
| 刘建军等.糜烂性胃炎的中医治疗进展.《中医药信息》.2006,第23卷(第05期),16-18. * |
| 史凤桐.徐振盛治疗慢性萎缩性胃炎经验.《中国中西医结合消化杂志》.1994,第2卷(第03期),32-33. * |
| 张爱国.慢性萎缩性胃炎中医治疗近况.《中国医药学报》.2002,第17卷(第06期),371-374. * |
| 张绍江.中药治疗疣状胃炎19例.《河北中医》.2001,第23卷(第04期),293. * |
| 徐玉锦.慢性萎缩性胃炎的中医辨证治疗及研究进展.《吉林中医药》.2006,第26卷(第08期),69-70. * |
| 梁光宇等.中医药治疗慢性萎缩性胃炎概况.《湖北中医杂志》.2007,第29卷(第11期),64-65. * |
| 王星田等.李鸣皋治胃脘痛经验简介.《国医论坛》.1991,(第05期),18-20. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101757559A (en) | 2010-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102949630B (en) | Traditional Chinese medicine composition for treating abdominal distension caused by lack of gastrointestinal motility | |
| CN102068677A (en) | Chinese medicament for treating spleen and stomach deficiency-cold | |
| CN102309696B (en) | Traditional Chinese medicine for treating gastric ulcer | |
| CN101129966A (en) | Traditional Chinese medicine for treating thyroid hyperfunction companioned with diarrhea | |
| CN101757559B (en) | Medicament for treating gastropathy | |
| CN103463583A (en) | Gastrointestinal disease treatment Chinese herbal | |
| CN103816463A (en) | Traditional Chinese medicinal composition for treating chronic colitis | |
| CN103169931A (en) | Traditional Chinese medicine composition for treating spleen-deficiency abdominal distention | |
| CN103735972B (en) | A kind of medicine treating senile urinary incontinence and preparation method thereof | |
| CN102266397A (en) | Chinese medicinal composition for treating rheumatic heart disease | |
| CN105250873A (en) | Traditional Chinese medicine composition for treating pregnancy vomiting | |
| CN103212013B (en) | Chinese medicinal composition for treating epigastric pain | |
| CN102872342B (en) | Chinese medicinal composition for treating gastric ulcer | |
| CN105797050A (en) | Traditional Chinese medicine for treating stomach illness | |
| CN102327410B (en) | Traditional Chinese medicine composition for treating epigastric fullness | |
| CN103550690A (en) | Traditional Chinese medicine composition for treating superficial gastritis | |
| CN103356840A (en) | Medicament for treating cold | |
| CN102579787A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN104161922A (en) | Traditional Chinese medicine for treating qi deficiency-type cough | |
| CN101829312A (en) | Medicament for treating rheumatoid arthritis and preparation method thereof | |
| CN101596299A (en) | A kind of Chinese medicine pill for the treatment of precancerous lesions of chronic atrophic gastritis | |
| CN108144006A (en) | Nourishing the liver, the Chinese medicine of protect liver | |
| CN105902766A (en) | Peptic ulcer treating medicine and preparation method thereof | |
| CN105056194A (en) | Chinese herb composition for treating liver-qi stomach attacking and cold-heat mixed type chronic gastritis | |
| CN102940860A (en) | Traditional Chinese medicine composition for treating recurrent oral ulcer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120725 Termination date: 20141215 |
|
| EXPY | Termination of patent right or utility model |